Abbott India (BOM:500488) Cyclically Adjusted Revenue per Share: ₹2,710.87 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:500488 Abbott India Ltd BOM:500488
75 GF Score
Price ₹28,008.80
GF Value ₹32,655.43
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Abbott India Cyclically Adjusted Revenue per Share?

Abbott India BOM:500488 +1.67% 75 Cyclically Adjusted Revenue per Share is ₹2,710.87 as of Mar. 2026. GuruFocus rates BOM:500488 with a GF Score™ of 75/100 and a GF Value™ of ₹32,655.43 (Modestly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Abbott India's adjusted revenue per share for the three months ended in Mar. 2026 was ₹804.475. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹2,710.87 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Abbott India's average Cyclically Adjusted Revenue Growth Rate was 9.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 9.70% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 10.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Abbott India was 10.80% per year. The lowest was 9.70% per year. And the median was 10.30% per year.

As of today (2026-08-12), Abbott India's current stock price is ₹28008.80. Abbott India's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was ₹2,710.87. Abbott India's Cyclically Adjusted PS Ratio of today is 10.33.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Abbott India was 14.15. The lowest was 8.63. And the median was 10.64.


Abbott India  (BOM:500488) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Abbott India's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=28008.80/2710.87
=10.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Abbott India was 14.15. The lowest was 8.63. And the median was 10.64.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Abbott India Cyclically Adjusted Revenue per Share Related Terms


Abbott India Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Abbott India's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott India Cyclically Adjusted Revenue per Share Chart

Abbott India Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,830.72 2,054.68 2,276.50 2,473.34 2,710.87

Abbott India Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,473.34 2,542.41 2,617.58 2,665.80 2,710.87

BOM:500488 vs ZTS: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Abbott India's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott India Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abbott India's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Abbott India's Cyclically Adjusted PS Ratio falls into.


BOM:500488
75GF Score
Abbott India Ltd BOM:500488
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbott India Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Abbott India's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=804.475/164.2724*164.2724
=804.475

Current CPI (Mar. 2026) = 164.2724.

Abbott India Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 343.193 105.961 532.055
201609 339.314 105.961 526.041
201612 351.280 105.196 548.553
201703 332.028 105.196 518.490
201706 328.387 107.109 503.646
201709 438.149 109.021 660.199
201712 414.819 109.404 622.860
201803 371.028 109.786 555.166
201806 397.647 111.317 586.817
201809 461.045 115.142 657.771
201812 445.932 115.142 636.209
201903 425.136 118.202 590.836
201906 470.066 120.880 638.807
201909 496.376 123.175 661.992
201912 507.388 126.235 660.274
202003 451.535 124.705 594.801
202006 500.833 127.000 647.818
202009 496.400 130.118 626.699
202012 515.468 130.889 646.938
202103 514.448 131.771 641.339
202106 573.070 134.084 702.093
202109 575.087 135.847 695.421
202112 576.169 138.161 685.062
202203 586.459 138.822 693.976
202206 613.704 142.347 708.230
202209 649.096 144.661 737.092
202212 622.236 145.763 701.250
202303 631.156 146.865 705.967
202306 695.967 150.280 760.767
202309 703.158 151.492 762.479
202312 676.269 152.924 726.453
202403 676.288 153.035 725.950
202406 732.993 155.789 772.908
202409 768.315 157.882 799.412
202412 759.661 158.323 788.208
202503 755.066 157.552 787.275
202506 818.047 159.755 841.178
202509 826.894 162.289 836.999
202512 811.313 163.281 816.240
202603 804.475 164.272 804.475

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹2,710.87 mean?
Abbott India (BOM:500488) has a Cyclically Adjusted Revenue per Share of ₹2,710.87 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Abbott India and its competitors.
Is Abbott India's Cyclically Adjusted Revenue per Share too high?
Abbott India's current Cyclically Adjusted Revenue per Share is ₹2,710.87. Overall, Abbott India has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abbott India's Cyclically Adjusted Revenue per Share compare to ZTS?
Abbott India's Cyclically Adjusted Revenue per Share of ₹2,710.87 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Abbott India and its competitors. Abbott India's current Cyclically Adjusted Revenue per Share is ₹2,710.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott India stock overvalued right now?
Based on GuruFocus' analysis, Abbott India (BOM:500488) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹32,655.43, compared to a current price of ₹28,008.80 — trading 14.2% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹2,710.87. Abbott India's overall GF Score™ is 75/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Abbott India (BOM:500488), the current Cyclically Adjusted Revenue per Share is ₹2,710.87 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbott India (BOM:500488) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott India stock appears to be undervalued. The current stock price of ₹28,008.80 is trading 14.2% below its estimated GF Value™ of ₹32,655.43. GuruFocus considers Abbott India to be Modestly Undervalued.

Key valuation signals for BOM:500488:

  • Cyclically Adjusted Revenue per Share: ₹2,710.87
  • GF Value™: ₹32,655.43 vs. price of ₹28,008.80 (14.2% below fair value)
  • GF Score™: 75/100 with 1 warning sign

No single metric tells the full story. See the BOM:500488 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Abbott India Business Description

Other Exchanges ABBOTINDIA:India
Address Plot C-68, G Block, 16th Floor, Godrej BKC, Near MCA Club, Bandra-Kurla Complex, Bandra (East), Mumbai, MH, IND, 400051
Abbott India Ltd is a drug manufacturing company that offers products in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. Its patient focus centers overwhelmingly on women's health and gastrointestine, gastroenterology, and hepatic care. Geographically, the majority of the company's revenue is generated in India.
75GF Score

Get the complete analysis for BOM:500488

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹28,008.80
Price
₹32,655.43
GF Value